Page 259 - Vitamin D and Cancer

246 C.M. Barnett and T.M. Beer

108. Ahmed S, Johnson CS, Rueger RM et al (2002) Calcitriol (1, 25-dihydroxycholecalciferol)
potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate
cancer model. J Urol 168:756–761
109. Light BW, Yu WD, McElwain MC et al (1997) Potentiation of cisplatin antitumor activity
using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res
57:3759–3764
110. Wieder R, Wang Q, Uytingco M et al (1998) 1, 25-dihydroxyvitamin D3 and all-trans retinoic
acid promote apoptosis and sensitize breast cancer cells to the effects of chemotherapeutic
agents. Proc Am Soc Clin Oncol 17:107a
111. Sundaram S, Chaudhry M, Reardon D et al (2000) The vitamin D3 analog EB 1089 enhances
the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells. Breast
Cancer Res Treat 63:1–10
112. Torres R, Calle C, Aller P et al (2000) Etoposide stimulates 1, 25-dihydroxyvitamin D3 dif-
ferentiation activity, hormone binding and hormone receptor expression in HL-60 human
promyelocytic cells. Mol Cell Biochem 208:157–162
113. Koga M, Sutherland RL (1991) Retinoic acid acts synergistically with 1, 25-dihydroxyvitamin
D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation. J Steroid Biochem
Mol Biol 39:455–460
114. Guzey M, Sattler C, DeLuca HF (1998) Combinational effects of vitamin D3 and retinoic
acid (all trans and 9 cis) on proliferation, differentiation, and programmed cell death in two
small cell lung carcinoma cell lines. Biochem Biophys Res Commun 249:735–744
115. Peehl DM, Feldman D (2004) Interaction of nuclear receptor ligands with the Vitamin D
signaling pathway in prostate cancer. J Steroid Biochem Mol Biol 92:307–315
116. Ikeda N, Uemura H, Ishiguro H et al (2003) Combination treatment with 1alpha,
25- dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase
reverse transcriptase transcription in prostate cancer cells. Mol Cancer Ther 2:739–746
117. Anzano MA, Smith JM, Uskokovic MR et al (1994) 1 alpha, 25-Dihydroxy-16-ene-23-yne-26,
27-hexafluorocholecalciferol (Ro24–5531), a new deltanoid (vitamin D analogue) for preven-
tion of breast cancer in the rat. Cancer Res 54:1653–1656
118. Welsh J (1994) Induction of apoptosis in breast cancer cells in response to vitamin D and
antiestrogens. Biochem Cell Biol 72:537–545
119. Abe-Hashimoto J, Kikuchi T, Matsumoto T et al (1993) Antitumor effect of 22-oxa-calcitriol,
a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma
and its synergism with tamoxifen. Cancer Res 53:2534–2537
120. Christensen GL, Jepsen JS, Fog CK et al (2004) Sequential versus combined treatment of human
breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of
predictive markers for vitamin D treatment. Breast Cancer Res Treat 85:53–63
121. Moreno J, Krishnan AV, Swami S et al (2005) Regulation of prostaglandin metabolism by
calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res 65:7917–7925
122. Gavrilov V, Steiner M, Shany S (2005) The combined treatment of 1, 25-dihydroxyvitamin
D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate
cancer cell line (LNCaP) growth. Anticancer Res 25:3425–3429
123. Hsiao M, Tse V, Carmel J et al (1997) Functional expression of human p21(WAF1/CIP1)
gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity.
Biochem Biophys Res Commun 233:329–335
124. Dunlap N, Schwartz GG, Eads D et al (2003) 1alpha, 25-dihydroxyvitamin D(3) (calcitriol)
and its analogue, 19-nor-1alpha, 25(OH)(2)D(2), potentiate the effects of ionising radiation
on human prostate cancer cells. Br J Cancer 89:746–753
125. Polar MK, Gennings C, Park M et al (2003) Effect of the vitamin D3 analog ILX 23–7553
on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal human
fibroblasts. Cancer Chemother Pharmacol 51:415–421
126. DeMasters GA, Gupta MS, Jones KR et al (2004) Potentiation of cell killing by fractionated
radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the vitamin
D3 analog EB 1089. J Steroid Biochem Mol Biol 92:365–374